NewLimit CEO @jacobkimmel explains the clinical trial bottleneck AI can't fix: biology has irreducible latency "It's unlikely we're gonna see rapid expedition of clinical trials because a lot of the periods of time can't be expedited based on the biological primitives. In computer science you often have a notion of bandwidth and latency." "There are some irreducible latencies in clinical trials. If you wanna give a drug to a patient and see if they're healthy a month later, it's not like you can enroll 30 patients and check back in one day. You just need to wait a full month. The classic nine people can't have a baby in one month story." "The other thing we can hope for is that the success rate might improve. Right now, rough math, roughly 9 out of 10 drugs that go into the clinic will ultimately fail." "If you're able to even just 2X that success rate, getting to 20% success rather than 10%, then you would double the number of drugs that come out every year, and you would cut the effective cost in half." @newlimit